@article{8a3eaccd83b94ef8ba4750ae5d9a0514,
title = "The association of smoking and surgery in inflammatory bowel disease is modified by age at diagnosis",
abstract = "OBJECTIVES: We assessed the association of smoking at diagnosis of inflammatory bowel disease (IBD) on the need for an intestinal resection. METHODS: The Health Improvement Network was used to identify an inception cohort of Crohn s disease (n=1519) and ulcerative colitis (n=3600) patients from 1999 2009. Poisson regression explored temporal trends for the proportion of newly diagnosed IBD patients who never smoked before their diagnosis and the risk of surgery within 3 years of diagnosis. Cox proportional hazard models assessed the association between smoking and surgery, and effect modification was explored for age at diagnosis. RESULTS: The rate of never smokers increased by 3% per year for newly diagnosed Crohn s disease patients (incidence rate ratio (IRR) 1.03; 95% confidence interval (CI): 1.02 1.05), but not for ulcerative colitis. The rate of surgery decreased among Crohn s disease patients aged 17 40 years (IRR 0.96; 95% CI: 0.93 0.98), but not for ulcerative colitis. Smoking at diagnosis increased the risk of surgery for Crohn s disease patients diagnosed after the age of 40 (hazard ratio (HR) 2.99; 95% CI: 1.52 5.92), but not for those diagnosed before age 40. Ulcerative colitis patients diagnosed between the ages of 17 and 40 years and who quit smoking before their diagnosis were more likely to undergo a colectomy (ex-smoker vs. never smoker: HR 1.66; 95% CI: 1.04 2.66). The age-specific findings were consistent across sensitivity analyses for Crohn s disease, but not ulcerative colitis. CONCLUSIONS: In this study, the association of smoking and surgical resection was dependent on the age at diagnosis of IBD.",
author = "Frolkis, {Alexandra D.} and {De Bruyn}, Jennifer and Nathalie Jette and Mark Lowerison and Jordan Engbers and William Ghali and James Lewis and Isabelle Vallerand and Scott Patten and Bertus Eksteen and Cheryl Barnabe and Remo Panaccione and Subrata Ghosh and Samuel Wiebe and Kaplan, {Gilaad G.}",
note = "Funding Information: Guarantor of the article: Gilaad G. Kaplan, MD, MPH, FRCPC. Specific author contributions: Study concept and design, acquisition of data, analysis and interpretation of data, and drafting of the manuscript: Alexandra D. Frolkis; acquisition of data, analysis and interpretation of data, and critical revision of the manuscript: Mark Lowerison, Jordan Engbers, and Samuel Wiebe; interpretation of data and critical revision of the manuscript: Jennifer deBruyn, Nathalie Jette, William Ghali, Bertus Eksteen, Scott Patten, James Lewis, Isabelle Vallerand, Remo Panaccione, Subrata Ghosh, and Cheryl Barnabe; study concept and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, and study supervision: Gilaad G. Kaplan. Financial support: Gilaad G. Kaplan is supported through a New Investigator Award from the Canadian Institute of Health Research and a Population Health Investigator Award from Alberta-Innovates Health-Solutions. Jette holds a Canada Research Chair in Neurological Health Services Research and an Alberta Innovates Health Solutions Population Health Investigator Award. Alexandra Frolkis holds an Alberta Innovates Health Solutions MD/PhD Studentship. Potential competing interests: None. Publisher Copyright: {\textcopyright} 2016 Lippincott Williams and Wilkins. All rights reserved.",
year = "2016",
month = apr,
day = "1",
doi = "10.1038/ctg.2016.21",
language = "English",
volume = "7",
journal = "Clinical and Translational Gastroenterology",
issn = "2155-384X",
publisher = "Nature Publishing Group",
number = "4",
}